These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 17565242)
41. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Kato H; Sato A; Fukuda H; Kagami Y; Udagawa H; Togo A; Ando N; Tanaka O; Shinoda M; Yamana H; Ishikura S Jpn J Clin Oncol; 2009 Oct; 39(10):638-43. PubMed ID: 19549720 [TBL] [Abstract][Full Text] [Related]
42. Endoscopic submucosal dissection of recurrent or residual superficial esophageal cancer after chemoradiotherapy. Saito Y; Takisawa H; Suzuki H; Takizawa K; Yokoi C; Nonaka S; Matsuda T; Nakanishi Y; Kato K Gastrointest Endosc; 2008 Feb; 67(2):355-9. PubMed ID: 18226703 [TBL] [Abstract][Full Text] [Related]
43. Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining. Gockel I; Domeyer M; Sgourakis GG; Schimanski CC; Moehler M; Kirkpatrick CJ; Lang H; Junginger T; Hansen T J Surg Oncol; 2009 Sep; 100(3):191-8. PubMed ID: 19548259 [TBL] [Abstract][Full Text] [Related]
44. High orotate phosphoribosyltransferase gene expression predicts complete response to chemoradiotherapy in patients with squamous cell carcinoma of the esophagus. Kajiwara T; Nishina T; Hyodo I; Moriwaki T; Endo S; Nasu J; Hori S; Matsuura B; Hiasa Y; Onji M Oncology; 2009; 76(5):342-9. PubMed ID: 19307741 [TBL] [Abstract][Full Text] [Related]
45. Treatment of Barrett's esophagus with high-grade dysplasia. McAllaster JD; Buckles D; Al-Kasspooles M Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509 [TBL] [Abstract][Full Text] [Related]
46. Treatment of locally advanced esophageal cancer with surgery and chemoradiation. Siersema PD; van Hillegersberg R Curr Opin Gastroenterol; 2008 Jul; 24(4):535-40. PubMed ID: 18622172 [TBL] [Abstract][Full Text] [Related]
47. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663 [TBL] [Abstract][Full Text] [Related]
48. Radiation therapy for esophageal cancer in Japan: results of the Patterns of Care Study 1999-2001. Kenjo M; Uno T; Murakami Y; Nagata Y; Oguchi M; Saito S; Numasaki H; Teshima T; Mitsumori M Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):357-63. PubMed ID: 19735863 [TBL] [Abstract][Full Text] [Related]
49. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma. Gotoh M; Takiuchi H; Kawabe S; Ohta S; Kii T; Kuwakado S; Katsu K Jpn J Clin Oncol; 2007 Sep; 37(9):652-7. PubMed ID: 17940077 [TBL] [Abstract][Full Text] [Related]
50. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases. Lee PC; Port JL; Paul S; Stiles BM; Altorki NK Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222 [TBL] [Abstract][Full Text] [Related]
51. Recent progress in multidisciplinary treatment for patients with esophageal cancer. Watanabe M; Otake R; Kozuki R; Toihata T; Takahashi K; Okamura A; Imamura Y Surg Today; 2020 Jan; 50(1):12-20. PubMed ID: 31535225 [TBL] [Abstract][Full Text] [Related]
52. Early-stage adenocarcinoma in Barrett's esophagus: aspects of surgical therapies. Horváth OP; Kalmár K Dig Dis; 2009; 27(1):45-53. PubMed ID: 19439960 [TBL] [Abstract][Full Text] [Related]
53. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus. Chao YK; Chan SC; Chang HK; Liu YH; Wu YC; Hsieh MJ; Tseng CK; Liu HP Eur J Surg Oncol; 2009 Mar; 35(3):289-94. PubMed ID: 18396384 [TBL] [Abstract][Full Text] [Related]
54. Endoscopic mucosal resection for early squamous-cell cancer of the esophagus--a dangerous game or standard treatment? Hölscher AH Endoscopy; 2007 Jan; 39(1):77-9. PubMed ID: 17323470 [No Abstract] [Full Text] [Related]
56. [Salvage surgery in esophageal cancer treatment -- its review in this decade and promises for the next decade]. Hokamura N Gan To Kagaku Ryoho; 2011 Feb; 38(2):179-83. PubMed ID: 21368480 [TBL] [Abstract][Full Text] [Related]
57. [Trends in widening application of endoscopic therapy for early-stage esophageal neoplasms]. Monma K Nihon Naika Gakkai Zasshi; 2003 Jan; 92(1):10-20. PubMed ID: 12652697 [No Abstract] [Full Text] [Related]
58. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854 [TBL] [Abstract][Full Text] [Related]
59. Diagnosis by endoscopic mucosal resection of a rare esophageal squamous cell carcinoma mimicking a subepithelial tumor. Chuang CS; Lee IL; Lee KF; Tung SY; Wu CS Endoscopy; 2007 Feb; 39 Suppl 1():E301-2. PubMed ID: 17957647 [No Abstract] [Full Text] [Related]
60. Treatment of Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma. Zehetner J; DeMeester SR Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):493-8. PubMed ID: 19817671 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]